Childhood Cancer in India – Current Scenario
India has about 380 million children under 14 years. A recent study in The Lancet Regional Health Southeast Asia shows that India accounts for 68.6% (25,939) of all new childhood cancer cases in the SAARC region in 2022. The most common cancer is leukaemia, followed by central nervous system tumours.
Key Developments
- Estimates: 37,716 new childhood cancer cases and 17,698 deaths in SAARC (2022); India alone: 25,939 cases.
- Data source: GLOBOCAN 2022 provides the baseline, but coverage is limited.
- Survival: Cure rates for leukaemia can reach 80‑90% with early diagnosis; however, nationwide cure rates remain below 30% in many low‑ and middle‑income settings.
- Policy: Ayushman Bharat covers initial treatment in government hospitals, but relapse or private care can exceed this limit.
Important Facts
1. Cancer registries currently cover only about 15% of the Indian population, mainly urban areas. Rural gaps lead to under‑reporting.
2. The Supreme Court (11 August 2026) ordered the remaining 19 states and UTs to declare cancer a notifiable disease, aiming to improve data capture.
3. Specialized infrastructure is expanding: every state now has a government‑run Regional Cancer Centre, and centres linked to Tata Memorial Hospital and AIIMS are increasing access.
4. Financial barriers remain critical. Even with Ayushman Bharat, costs of investigations, hospitalisation and expensive relapse drugs push many families toward treatment abandonment.
Exam Relevance
The issue intersects multiple GS papers. GS2 (Polity) examines the role of central and state governments in health governance and the Supreme Court’s directive. GS3 (Economy & Health) covers disease burden, health financing, and the impact of schemes like Ayushman Bharat. GS4 (Ethics) raises questions about equity, access to life‑saving treatment, and the moral responsibility of the state.
Way Forward
- National Cancer Registry: Expand coverage to 100% of the population, include rural data, and record staging, treatment and outcomes.
- Early Diagnosis: Strengthen primary‑level screening, train school health workers, and create awareness campaigns.
- Financial Protection: Increase Ayushman Bharat ceiling for oncology, subsidise relapse drugs, and involve NGOs for gap‑filling.
- Infrastructure: Upgrade existing Regional Cancer Centres, ensure pediatric oncology units in district hospitals, and improve referral pathways.
- Research & Monitoring: Use registry data to study socioeconomic and environmental risk factors, guiding targeted interventions.
Addressing these gaps can move India from a situation where many children die of treatable cancers to one where survival exceeds 80 % nationwide, aligning with the nation’s health‑for‑all agenda.